TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV
Diseases associated with porcine circovirus type 2 (PCV2) and pseudorabies virus (PRV) significantly affect the economy of pig farms, particularly when combined infections lead to bacterial co-infections. Antigens from the pseudorabies variant strain gB and gD proteins and PCV2 (genotyped) Cap prote...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Veterinary Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-7381/12/1/25 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832587338761371648 |
---|---|
author | Fulai Yu Wei Xiang Weiye Ou Yang Li Xinbiao Shu Xiaoliang Li |
author_facet | Fulai Yu Wei Xiang Weiye Ou Yang Li Xinbiao Shu Xiaoliang Li |
author_sort | Fulai Yu |
collection | DOAJ |
description | Diseases associated with porcine circovirus type 2 (PCV2) and pseudorabies virus (PRV) significantly affect the economy of pig farms, particularly when combined infections lead to bacterial co-infections. Antigens from the pseudorabies variant strain gB and gD proteins and PCV2 (genotyped) Cap protein were mixed with the pattern recognition receptor (PRR) agonist FLICd as adjuvants and formulated with a micro-hydrogel adjuvant into PCV2 and PRV bivalent subunit vaccines. Twenty pigs, aged 30–35 days, were divided into groups A (received bivalent subunit vaccine) and B (received bivalent subunit vaccines with recombinant FLICd adjuvant), as well as C (non-vaccinated challenge control) and D (blank control). Groups A and B showed no significant difference in average daily weight gain compared to the unvaccinated controls. Fourteen days post-second vaccination, groups A and B exhibited significantly higher levels of PRV and PCV2 antibodies than groups C and D. Group B showed significantly higher average titers of PRV-specific neutralizing antibodies than group A. Fourteen days post-second vaccination, a PRV (ZJM-1 strain) challenge test was conducted. The vaccinated group achieved 100% protection. Vaccination effectively reduced virus load post-challenge and shortened the PRV shedding period. Vaccination with PCV2 and PRV bivalent subunit vaccines effectively prevents the onset of PCV2-related diseases and infections by wild pseudorabies strains. |
format | Article |
id | doaj-art-1be3e3d0918b4282904072f96caddc8f |
institution | Kabale University |
issn | 2306-7381 |
language | English |
publishDate | 2025-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Veterinary Sciences |
spelling | doaj-art-1be3e3d0918b4282904072f96caddc8f2025-01-24T13:52:01ZengMDPI AGVeterinary Sciences2306-73812025-01-011212510.3390/vetsci12010025TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRVFulai Yu0Wei Xiang1Weiye Ou2Yang Li3Xinbiao Shu4Xiaoliang Li5Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, ChinaZhejiang Dovro Animal Health Products Co., Ltd., 298 Binhong West Road, Jinhua 321017, ChinaZhejiang MEBOLO Biotechnology Co., Ltd., Binhong West Road, Jinhua 321017, ChinaZhejiang Dovro Animal Health Products Co., Ltd., 298 Binhong West Road, Jinhua 321017, ChinaZhejiang Dovro Animal Health Products Co., Ltd., 298 Binhong West Road, Jinhua 321017, ChinaDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou 310058, ChinaDiseases associated with porcine circovirus type 2 (PCV2) and pseudorabies virus (PRV) significantly affect the economy of pig farms, particularly when combined infections lead to bacterial co-infections. Antigens from the pseudorabies variant strain gB and gD proteins and PCV2 (genotyped) Cap protein were mixed with the pattern recognition receptor (PRR) agonist FLICd as adjuvants and formulated with a micro-hydrogel adjuvant into PCV2 and PRV bivalent subunit vaccines. Twenty pigs, aged 30–35 days, were divided into groups A (received bivalent subunit vaccine) and B (received bivalent subunit vaccines with recombinant FLICd adjuvant), as well as C (non-vaccinated challenge control) and D (blank control). Groups A and B showed no significant difference in average daily weight gain compared to the unvaccinated controls. Fourteen days post-second vaccination, groups A and B exhibited significantly higher levels of PRV and PCV2 antibodies than groups C and D. Group B showed significantly higher average titers of PRV-specific neutralizing antibodies than group A. Fourteen days post-second vaccination, a PRV (ZJM-1 strain) challenge test was conducted. The vaccinated group achieved 100% protection. Vaccination effectively reduced virus load post-challenge and shortened the PRV shedding period. Vaccination with PCV2 and PRV bivalent subunit vaccines effectively prevents the onset of PCV2-related diseases and infections by wild pseudorabies strains.https://www.mdpi.com/2306-7381/12/1/25PCV2PRVbivalent subunit vaccinepattern recognition receptors |
spellingShingle | Fulai Yu Wei Xiang Weiye Ou Yang Li Xinbiao Shu Xiaoliang Li TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV Veterinary Sciences PCV2 PRV bivalent subunit vaccine pattern recognition receptors |
title | TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV |
title_full | TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV |
title_fullStr | TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV |
title_full_unstemmed | TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV |
title_short | TLR Agonist Immunoadjuvants Provide Effective Protection Against PCV2 and PRV Infections in a Bivalent Subunit Vaccine for PCV2 and PRV |
title_sort | tlr agonist immunoadjuvants provide effective protection against pcv2 and prv infections in a bivalent subunit vaccine for pcv2 and prv |
topic | PCV2 PRV bivalent subunit vaccine pattern recognition receptors |
url | https://www.mdpi.com/2306-7381/12/1/25 |
work_keys_str_mv | AT fulaiyu tlragonistimmunoadjuvantsprovideeffectiveprotectionagainstpcv2andprvinfectionsinabivalentsubunitvaccineforpcv2andprv AT weixiang tlragonistimmunoadjuvantsprovideeffectiveprotectionagainstpcv2andprvinfectionsinabivalentsubunitvaccineforpcv2andprv AT weiyeou tlragonistimmunoadjuvantsprovideeffectiveprotectionagainstpcv2andprvinfectionsinabivalentsubunitvaccineforpcv2andprv AT yangli tlragonistimmunoadjuvantsprovideeffectiveprotectionagainstpcv2andprvinfectionsinabivalentsubunitvaccineforpcv2andprv AT xinbiaoshu tlragonistimmunoadjuvantsprovideeffectiveprotectionagainstpcv2andprvinfectionsinabivalentsubunitvaccineforpcv2andprv AT xiaoliangli tlragonistimmunoadjuvantsprovideeffectiveprotectionagainstpcv2andprvinfectionsinabivalentsubunitvaccineforpcv2andprv |